LATEST ISSUE
November/December 2024
For almost half a century, the principal measure of value in cost-effectiveness analysis has been the quality-adjusted life year (QALY). Several organizations have offered frameworks that include additional value dimensions not captured by the QALY.
VOL. 8, NO. 5
September/October 2022
Valuing the Health of Children: Understanding What Drives Differences in Health Preferences for Children Versus Adults
VOL. 8, NO. S1
September 2022
A Plan of Action: Accelerating Patient Access to Next-Generation Sequencing in Oncology
